European Immunotherapy Net
The central resource platform for healthcare professionals and patients, giving you the latest news and updates on all areas of immunotherapy.
European Immunotherapy Net
The European Immunotherapy Net brings you the latest news and updates on all areas of immunotherapy. This platform offers healthcare professionals, nurses and patients access to the best in scientific publications, research, continuing medical education and more via a digital community that nurtures a transparent exchange of ideas, information, and activities. Powered by the European Hematology Association.
Featured: Risk-Adapted Preemptive Tocilizumab to Prevent Severe CRS After CTL019 for Pediatric B-Cell ALL: A Prospective Clinical Trial
Browse all scientific publicationsLatest News
EHA25 Virtual: CAR-T cell therapy in the real world
Managing complex CAR-T cell treatments in the clinical practice may be challenging, however several real-world data are currently available. Listen to Catherine Thieblemont discussing the main issues of CAR-T therapy delivery and results in the real life during the past EHA25 virtual congress.
Brexucabtagene Autoleucel Provides New Option for Patients With R/R MCL
Brexucabtagene autoleucel induced durable response in patients with relapsed/refractory mantle cell lymphoma, according to findings from the phase 2 ZUMA-2 trial, leading to an FDA approval for use in this patient population on July 24, 2020.
Patient Resource: Latest News on CAR T-Cell Therapy for Multiple Myeloma
How can CAR T-cell therapy be used to treat multiple myeloma, and what is the latest in CAR T-cell research? Is it getting closer to being an approved treatment option? What are we learning from clinical trials? And finally, what should patients know?
Research Highlights
Scientific Publications
Browse our collection of scientific publications on Immunotherapy to learn more about the latest research and developments in the field.
Read more
Grants
EHA Research Grants support talented junior researchers in advancing their career, e.g. towards becoming the leader of a research group. If you have ambition for advancing your career and you have the support of your department and institute, learn more about EHA's research grants.
Read more
Education Higlights
EHA25 Virtul: CAR-T cell therapy in the real world
Managing complex CAR-T cell treatments in the clinical practice may be challenging, however several real-world data are currently available. Listen to Catherine Thieblemont discussing the main issues of CAR-T therapy delivery and results in the real life during the past EHA25 virtual congress.
Read more
EHA25: The Present and Future of T cell-based Immunotherapy
A selection of videos from EHA25 are now available on the European Immunotherapy Net. In this article, presentations covering the increasingly growing field of T cell-based immunotherapy are shared.
Read more
Patient Highlights
Pediatrics
Whether you are a health care practitioner looking to expand your knowledge or a carer explaining immunotherapy to a child or its family for the first time, we are here to help. Explore the resource library for an overview of resources relating to pediatric patients.
Access resource library
Adults
While Immunotherapy has the power to change lives, it can be hard to find the information and support you need during treatment. Get an overview of the best information that will help you to understand your treatment, and direct you to the support you need by exploring the resource library.
Acess resource library
Nurses Highlights
The role of the coordinator nurse in the CAR-T treatment
In this video, Marlene Vercasson, from the Lyon Hospital, shares her experience in the local CAR-T program and Juliet international clinical trial.
Read more
Do mAbs and paraprotein affect COVID-19 Serological Testing in Patients with Multiple Myeloma?
SARS-CoV-2 (COVID-19) serology tests do not appear to interfere or cause cross-reactivity with therapeutic monoclonal antibody (t-mAb) treatments for hematologic malignancies (HM) such as multiple myeloma (MM), according to a study published in Diagnostics.
Read more